amino acid composition
Phase 1- Indications
- Cirrhosis, Hepatic insufficiency, Hepatic encephalopathy, Cirrhotic sarcopenia, End stage liver disease
Company intelligence / Profile preview
康比特
北京市昌平区, 北京市, 中国
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
康比特是一家中国领先的运动营养和健康食品企业，专注于蛋白粉、能量胶等产品，服务专业运动员、大众健身及军需市场。公司持续创新乳清蛋白等核心产品，并通过数字化体育科技服务提升用户体验。2024年上半年蛋白增肌类产品收入同比增长117.08%。[2][4]
- Therapeutic areas
- Psychiatry
- Industry
- Food & Nutrition
02
Drug pipeline
1 assetBeyond the preview
Go deeper on 康比特.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 康比特.